CHEMICAL AND PHYSICAL PROPERTIES
Boiling Point | Decomposes at 214 ºC |
---|---|
Melting Point | > 214 ºC |
Solubility | 0.02 mg/ml (in the form of di-HCl monohydrate salt) |
LogP | 2.28 |
Caco2 Permeability | 5.98e-06 |
Dissociation Constants | 6 |
COMPUTED DESCRIPTORS
Molecular Weight | 374.4 g/mol |
---|---|
XLogP3 | 2.4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 374.18550935 g/mol |
Monoisotopic Mass | 374.18550935 g/mol |
Topological Polar Surface Area | 96.8 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 595 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Glasdegib is a member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a (2R,4S)-4-{[(4-cyanophenyl)carbamoyl]amino}-1-methylpiperidin-2-yl group at position 2. It is a hedgehog signalling pathway inhibitor that acts by binding to Smoothened (SMO) receptors and blocking signal transduction (IC50 = 5 nM). It is used in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients (aged >= 75 years), or who have medical conditions that prevent the use of standard chemotherapy. It has a role as a SMO receptor antagonist, a Hedgehog signaling pathway inhibitor and an antineoplastic agent. It is a member of benzimidazoles, a member of piperidines, a member of phenylureas and a nitrile.